The ability of the allergen-specific mRNA-LNP to induce high levels of anti-allergen IgG isotypes, which likely include blocking antibodies, and reduce allergen-specific IgE in a preventive model underscores the potential utility of this approach in treating antibody-dependent allergic diseases, including food allergy, a subject that deserves attention. The gene discussed is IGHE; the disease is allergic disease.